Results 61 to 70 of about 40,526 (207)

Evaluation of Initial Enoxaparin Dosing and Antifactor Xa Levels in Infants Admitted to the Neonatal Intensive Care Unit

open access: yesBiomedicine Hub
Introduction: Infants are at risk for thrombotic conditions due to multiple risk factors such as congenital heart defects and sepsis. According to the American College of Chest Physicians (ACCP) 2012 guidelines, enoxaparin may be given for thrombotic ...
Rosemarie Nagy   +3 more
doaj   +1 more source

Medial hinge fracture after closing wedge high tibial osteotomy: Proposing a new classification and risk factor analysis of a neglected complication

open access: yesKnee Surgery, Sports Traumatology, Arthroscopy, EarlyView.
Abstract Purpose Contralateral hinge fracture is one of the most common complications of medial opening wedge high tibial osteotomy (HTO), however, this complication has been poorly investigated after closing‐wedge HTO (CW‐HTO). The primary aim of this study was to describe the incidence and characteristics and propose a classification system of medial
Gian Andrea Lucidi   +5 more
wiley   +1 more source

Obtaining the Enoxaparin Sodium Substance Equivalent to the Original Clexane® and Lovenox®. The Selection of Technological Parameters and Optimization of the “Greenness” of the Purification Stage

open access: yesЖурнал органічної та фармацевтичної хімії, 2023
The aim of the study was to adjust and optimize the purification stage of crude enoxaparin sodium to obtain a substance equivalent to the original drugs Clexane® and Lovenox® according to the criteria specified by the FDA. The purification stage involves
Yuliia V. Bovsunovska   +4 more
doaj   +1 more source

Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients. [PDF]

open access: yes, 2012
SummaryAnticoagulation therapy for the prevention of venous thromboembolic events is indicated in patients after major orthopaedic surgery and in hospitalised acutely ill medical patients, who have a high or moderate risk of venous thromboembolism (VTE),
Ageno W, Spyropoulos AC, Turpie AG
core   +1 more source

Outcomes and Risk Factors in Oncologic Temporal Bone Surgery: A Head and Neck‐Specific NSQIP Analysis

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective Advanced temporal bone and parotid gland malignancies are rare and difficult to manage. However, complications of oncologic temporal bone surgery have not been systematically categorized. We aim to detail the postoperative outcomes of lateral temporal bone resection (LTBR) and mastoidectomy for otologic oncology patients, and ...
Bailey H. Duhon   +5 more
wiley   +1 more source

Pancreatic ductal adenocarcinoma [PDF]

open access: yes, 2013
A 61-year-old gentleman who lives with his wife and 20-year-old son, presented to the polyclinic with a four week history of pruritus. On examination he was found to be jaundiced and his LFTs were high.
Bezzina, Sarah, Debattista, Daniel
core  

The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. [PDF]

open access: yes, 2017
The ENSURE-AF study (NCT 02072434) of anticoagulation for electrical cardioversion in nonvalvular atrial fibrillation (NVAF) showed comparable low rates of bleeding and thromboembolism between the edoxaban and the enoxaparin-warfarin treatment arms. This
Al-Saady, N   +4 more
core   +2 more sources

Utilization profile of enoxaparin in hospitalized patients with Chronic Kidney Disease in southern Brazil

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2020
Chronic Kidney Disease (CKD) patients usually require the use of anticoagulants for treatment or prevention of thromboembolic diseases. One such commonly used anticoagulant is enoxaparin. However, special attention is advised when using this drug for CKD
Carolina Araujo Cirne   +1 more
doaj   +1 more source

Correlation of Treatment Dose Enoxaparin with Anti-Xa Concentrations in Adult Hemodialysis Inpatients [PDF]

open access: yes, 2014
Enoxaparin, a low-molecular-weight-heparin, is being used in hemodialysis patients despite a lack of guideline or manufacturer dose recommendations.
Anguelov, Miroslav A.   +3 more
core   +1 more source

Retrospective Evaluation of Venous Thromboembolism Prophylaxis in the Adult Cancer Population [PDF]

open access: yes, 2009
Study objectives. Hospitalized cancer patients are at an increased risk for venous thromboembolism (VTE) and it is recommended they receive pharmacologic prophylaxis unless otherwise contraindicated.
Liu, Chin Y., Reeves, David J.
core   +2 more sources

Home - About - Disclaimer - Privacy